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Disclaimer: This guideline is designed primarily as an educational resource for healthcare providers to help them provide quality
medicalgeneticservices.Adherencetothisguidelinedoesnotnecessarilyassureasuccessfulmedicaloutcome.Thisguidelineshould
not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed
toobtainingthesameresults.Indeterminingtheproprietyofanyspecificprocedureortest,thegeneticistshouldapplyhisorherown
professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It may be prudent,
however, to document in the patient’s record the rationale for any significant deviation from this guideline.
In 1996, a practice guideline on genetic counseling for advanced paternal age was published. The current
document updates the state of knowledge of advanced paternal age effects on single gene mutations, chromo-
some anomalies, and complex traits. Genet Med 2008:10(6):457–460.
There is no clearly accepted definition of advanced paternal
age. A frequently used criterion is any man aged 40 years or
older at the time of conception. The current population mean
paternal age is 27 years.
Advancedpaternalageisassociatedwithanincreasedriskof
new gene mutations. Because of the large number of cell divi-
sions during spermatogenesis, the mutation rate for base sub-
stitutions is much higher in men than women, and increases
withpaternalage.Theriskforgeneticdefectsincreaseslinearly
forsomeconditions,andexponentiallyforothers.1–3Thecon-
ditions most strongly associated with advanced paternal age
are those caused by mutations in the form of single base sub-
stitutions in the FGFR2, FGFR3, and RET genes, and include
Pfeiffer syndrome, Crouzon syndrome, Apert syndrome,
achondroplasia, thanatophoric dysplasia, as well as MEN2A
and MEN2B.4 Some dominant conditions that are caused by
gene changes that include both point mutations and base pair
deletions (e.g., neurofibromatosis) show a lesser association
with paternal age. Other dominant conditions show no asso-
ciation with increased paternal age.5 Although Friedman6 had
estimated that the risk for autosomal dominant disorders af-
fectingoffspringoffathersaged40ormorewas0.3–0.5%,it is
now thought that the actual risk is lower.7 There is also a
growing body of evidence that advanced paternal age is as-
sociated with an increased risk for complex disorders such
as some congenital anomalies, schizophrenia, autism spec-
trum disorders, and some forms of cancer.8–12 For most
conditions the relative risk is two or less. However, the
mechanism for the increased risk is unknown, and in some
cases, the observed paternal age effect may be an artifact of
some other causative factor.
Ingeneral,forautosomesandsexchromosomes,thereisno
compelling evidence that chromosomal aberrations (aneu-
ploidy or structural chromosome abnormalities) are signifi-
cantlyincreasedinnewbornsaspaternalageincreases.Thelow
incidence of paternally derived extra chromosomes in tri-
somies combined with the relatively small number of children
fathered by older men makes it difficult to demonstrate a pa-
ternal age effect. Two possible exceptions are trisomy 21 and
Klinefeltersyndrome.RecentdataonDownsyndromesuggest
apaternalageeffect,eitheractingaloneorincombinationwith
a maternal age effect.13,14 This observation is supported by re-
ports of increased aneuploidy rates in sperm for some of the
chromosomes, including 21 and the sex chromosomes.15–17 In
summary,thereisawiderangeofgeneticdisordersthatmaybe
related to advanced paternal age (Table 1). Overall, it seems
that the risk of birth defects and some chromosome disorders
may be minimally increased, and the risk for later onset disor-
ders may also show a small increase with advanced paternal
age. There are currently no screening or diagnostic test panels
which specifically target those conditions that increase with
paternal age. If the older male’s partner is currently pregnant,
thepregnancyshouldbetreatedasanyotheraccordingtopre-
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Paternal age risks
Type Specific condition
Age
(relative to
reference age)
Relative risk
(CI, if available)
Population risk
(or reference risk) Adjusted risk
References
(first author’s
name only)
Autosomal
dominant
Achondroplasia 50 (25–29) 7.8 1/15,000 1/1923 Risch1
30–34 (20) 3.5 1/4285 Tiemann-Boege21
35–39 (20) 4 1/3750
40–44 (20) 8 1/1875
45–49 (20) 9 1/1666
50–54 (20) 12 1/1250
Apert 50 (25–29) 9.5 1/50,000 1/5263 Risch1
Pfeiffer 50 (25–29) 6 1/100,000 1/16,666 Glaser22
Crouzon 50 (25–29) 8 1/50,000 1/6250
Progeria Unknown Effect seen “Exceedingly rare”
MEN2A Unknown Effect seen 1/30,000
MEN2B Unknown Effect seen 1/30,000
Neurofibromatosis I 50 (25–29) 3.7
a 1/3000–1/4000 1/810–1/1080 Risch1
40 (30) 2.9 1/1034–1/1380 Bunin23
Osteogenesis
imperfecta
35 (25) 2.5 1/10,000 1/4000 Carothers24
35 (35) 1.37 (0.73–6.89) 1/7300 Orioli25
Thanatophoric
dysplasia
35 (35) 3.18 (1.48–6.89) 1/20,000–1/50,000 1/6290–1/15,723 Orioli25
Retinoblastoma 45 3
a (0.21–41.7) 1/15,000–1/20,000 1/5000–1/6667 Dockerty, Yip26,27
35 (35) 1.34 (1.04–1.74) 1/11,200–1/14,925 Moll28
50 (32.5) 5 1/3000–1/4000 DerKinderen29
Chromosomal Down syndrome 40–44 (20–29) 1.37 (0.48–3.86) 1/1200
(mat. age 20–29)
1/876 Zhu30
45–49 (20–29) 2.68 (0.76–9.51) 1/448
49 (20–29) 4.5 (1.0–20.3) 1/267
40–44 (25–29) 1.45 (1.26–1.68) Use maternal age
as baseline for
counseling
purposes
b
Yang31
45–49 (25–29) 1.28 (1.04–1.57)
49 (25–29) 1.39 (1.04–1.83)
None given “May be increased” Kuhnert16
None given “Paternal age effect in
association with maternal
age (35) effect”
Fisch14
Klinefelter syndrome 50 (20’s) 1.6
c (0.69–3.0) 1/500 men 1/312 men Lowe32
Congenital
anomalies
VSD 40 (40) 1.69
a 1/200 1/118 Olshan33
ASD 35 1.95
a 1/400 1/205 Lian11
Tracheoesophageal
fistula
50 (25–29) 2.55 (1.28–4.6) 1/3600 1/1412 Yang31
Other complex
disorders
Childhood leukemia 35 1.5 1/25,000 1/16,667 Murray34
40 (25) 1.14 (0.85–1.53) 1/21930 Yip27
Childhood CNS
tumor
30–34 (25) 1.34 (1.04–1.72) 1/36,000 1/26,866 Yip27
35–39 (25) 1.4 (1.04–1.86) 1/25,714
40 (25) 1.69 (1.21–2.35) 1/21,302
(Continued)
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and Gynecologists,18–20 with the prenatal counseling session
including a discussion about the potentially increased risk of
Down syndrome attributable to increased paternal age. Be-
cause of this and the possibility of ultrasound detection of
some of the features of the autosomal dominant conditions
noted above (e.g., thanatophoric dysplasia), an ultrasound is
recommended at 18–20-weeks gestation to evaluate fetal
growth and development. However, it is unlikely to detect
many of the conditions of interest. Prospective couples should
receive individualized genetic counseling to address specific
concerns.
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Type Specific condition
Age
(relative to
reference age)
Relative risk
(CI, if available)
Population risk
(or reference risk) Adjusted risk
References
(first author’s
name only)
Childhood type 1
diabetes
34 (25) 1.52 (1.1–2.09) 1/415 1/273 Cardwell35
Epilepsy 35–39 1.18 (1.02–1.26) 1/100 1/85 Vestergaard36
40–45 1.3 (1.08–1.55) 1/770
Schizophrenia 50 (20–24) 4.62 (2.28–9.36) 1/100 1/22 Rasmussen37
35–44 (15–24) 1.6 (1.0–2.6) 1/62.5 Zammit38
45–54 (15–24) 1.6 (0.8–3.1) 1/62.5
54 (15–24) 3.8 (1.3–11.8) 1/26
49 (25) 3 1/33 Malaspina12
32 (28) 3 (1.49–6.04) 1/33 Tsuchiya39
Autism 40 (30) 5.75 (2.65–12.46) 1/1000 1/174 Reichenberg40
Unknown Effect seen Cantor9
Autism spectrum
disorders
35–39 (25–29) 1.38 (1.04–1.84) 1/200 1/145 Croen41
39 (25–29) 1.52 (1.1–2.1) 1/131
Breast cancer 40 (30) 1.6 (1.04–2.32) 1/8.5 1/5.3 Choi42
Prostate cancer 38 (27) 1.7 (1.0–2.8) 1/5.9 1/3.5 Zhang43
Multiple sclerosis 51–55 (21–25) 2.0 (1.35–2.96) Montgomery44
Other Spontaneous
miscarriages
35 (35) 1.26 (1.0–1.6) 1/7 1/5.3 Slama45
39 (25–29) 1.6 (1.2–2.0) 1/4 Kleinhaus46
Relative infertility 39 (39) 2.3 (1.67–3.17) 1/14 couples 1/6.2 De la Rochebrochard47
Low birth weight 34 (20–34) 1.7 (1.3–2.2) 1/40 1/23 Reichman48
Preeclampsia 35–44 (25–34) 1.24 (1.05–1.46) 1/62 1/50 Harlap49
44 (25–34) 1.8 (1.04–1.51) 1/62 1/34
Total risk For 86 examined
congenital
anomalies
40 (20) 1.2 1/50 1/42 Lian11
50 (20) 1.3 1/38
This table is meant to show the findings of various studies examining the effect of paternal age on the condition in question. It is not meant to be a comprehensive
guide to counseling, but to merely indicate conditions which have been studied and results obtained from those studies.
aIncreased risk not shown by other studies.
bSuggestion for this adjustment made by the author of this document. There are no data regarding use of paternal age for counseling for serum screening results.
cBased on frequency of XY sperm.
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